Market Access, Payer, Access Economics and Reimbursement expertise in a broad range of complex medications including CarT, ImmunoOncology, Immunology and Neurology. Strong relationships and business acumen driving market access. Strengths include: Access Economics, Payer policy education and issue resolution, C-Suite Value presentations, Revenue Cycle Management, Reimbursement, Medicare and Commercial billing/coverage resolution, Specialty Pharmacy, as well as patient financial assistance. Expertise in facilitating a team environment across various levels of the organization including: Market Access, National Payer Accounts, Commercial Organization and third party vendors. Leadership expertise: Access economics, trade and distribution , Payer policy, Account Managment, Denial and appeal resolution, Reimbursement/Access support, Buy and Bill, Inpatient and out patient Billing and Coding, temporary billing codes, GPO Contracting, Revenue Cycle Management, C suite stakeholder consultations, strong Hospital, teaching institution and community oncology relationships , formulary approval , Staff Healthcare education, product acquisition, 340B pricing.